Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

274 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The optimal utilization proportion of external beam radiotherapy in European countries: An ESTRO-HERO analysis.
Borras JM, Lievens Y, Dunscombe P, Coffey M, Malicki J, Corral J, Gasparotto C, Defourny N, Barton M, Verhoeven R, van Eycken L, Primic-Zakelj M, Trojanowski M, Strojan P, Grau C. Borras JM, et al. Among authors: strojan p. Radiother Oncol. 2015 Jul;116(1):38-44. doi: 10.1016/j.radonc.2015.04.018. Epub 2015 May 14. Radiother Oncol. 2015. PMID: 25981052 Free article.
Role of radiotherapy in melanoma management.
Strojan P. Strojan P. Radiol Oncol. 2010 Mar;44(1):1-12. doi: 10.2478/v10019-010-0008-x. Epub 2010 Mar 18. Radiol Oncol. 2010. PMID: 22933884 Free PMC article.
IAEA-HypoX. A randomized multicenter study of the hypoxic radiosensitizer nimorazole concomitant with accelerated radiotherapy in head and neck squamous cell carcinoma.
Hassan Metwally MA, Ali R, Kuddu M, Shouman T, Strojan P, Iqbal K, Prasad R, Grau C, Overgaard J. Hassan Metwally MA, et al. Among authors: strojan p. Radiother Oncol. 2015 Jul;116(1):15-20. doi: 10.1016/j.radonc.2015.04.005. Epub 2015 Apr 22. Radiother Oncol. 2015. PMID: 25913070 Clinical Trial.
The impact of cancer incidence and stage on optimal utilization of radiotherapy: Methodology of a population based analysis by the ESTRO-HERO project.
Borras JM, Barton M, Grau C, Corral J, Verhoeven R, Lemmens V, van Eycken L, Henau K, Primic-Zakelj M, Strojan P, Trojanowski M, Dyzmann-Sroka A, Kubiak A, Gasparotto C, Defourny N, Malicki J, Dunscombe P, Coffey M, Lievens Y. Borras JM, et al. Among authors: strojan p. Radiother Oncol. 2015 Jul;116(1):45-50. doi: 10.1016/j.radonc.2015.04.021. Epub 2015 May 19. Radiother Oncol. 2015. PMID: 26002304 Free article.
Optimal radiotherapy utilisation rate in developing countries: An IAEA study.
Rosenblatt E, Barton M, Mackillop W, Fidarova E, Cordero L, Yarney J, Lim G, Abad A, Cernea V, Stojanovic-Rundic S, Strojan P, Kobachi L, Quarneti A. Rosenblatt E, et al. Among authors: strojan p. Radiother Oncol. 2015 Jul;116(1):35-7. doi: 10.1016/j.radonc.2015.06.012. Epub 2015 Jul 8. Radiother Oncol. 2015. PMID: 26164776
Radiotherapy quality assurance of the IAEA-HypoX trial of the accelerated radiotherapy in the treatment of head and neck squamous cell carcinoma with or without the hypoxic radiosensitizer nimorazole.
Hassan Metwally MA, Ali R, Kuddu M, Shouman T, Strojan P, Overgaard J, Grau C. Hassan Metwally MA, et al. Among authors: strojan p. Acta Oncol. 2015;54(9):1673-7. doi: 10.3109/0284186X.2015.1074721. Epub 2015 Sep 23. Acta Oncol. 2015. PMID: 26397148 No abstract available.
Radiotherapy utilization in developing countries: An IAEA study.
Rosenblatt E, Fidarova E, Zubizarreta EH, Barton MB, Jones GW, Mackillop WJ, Cordero L, Yarney J, Lim G, Gan JV, Cernea V, Stojanovic-Rundic S, Strojan P, Kochbati L, Quarneti A. Rosenblatt E, et al. Among authors: strojan p. Radiother Oncol. 2018 Sep;128(3):400-405. doi: 10.1016/j.radonc.2018.05.014. Epub 2018 May 30. Radiother Oncol. 2018. PMID: 29859755
274 results